Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses
Early-onset (pediatric and adolescent) multiple sclerosis (MS) is a well-established demyelinating disease that accounts for approximately 3-5% of all MS cases. Thus, identifying potential biomarkers that can reflect the pathogenic mechanisms, disease course and prognosis, and therapeutic response i...
Main Authors: | Maria P. Gontika, Maria C. Anagnostouli |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Multiple Sclerosis International |
Online Access: | http://dx.doi.org/10.1155/2018/8487471 |
Similar Items
-
Variation of the Myelin Oligodendrocyte Glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population
by: Cocco Eleonora, et al.
Published: (2007-05-01) -
Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01) -
Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
by: Maria-Eleni Androutsou, et al.
Published: (2020-10-01) -
Myelin Oligodendrocyte Glycoprotein Antibody Associated Transverse Myelitis
by: Iveta Chroustová, et al.
Published: (2019-01-01) -
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis
by: Menge Til, et al.
Published: (2011-11-01)